I'm excited to announce that our abstract, "PPM1D Somatic Mutations in Myeloid Neoplasms: Clinical Profile, Clonal Characteristics, and Impact of Concurrent Somatic TP53 Mutations," was presented as a poster at the ASH 2024 conference and published in the Blood Journal.
Check it out here: lnkd.in/guU3haQP.
A heartfelt thanks to the incredible Dr. Talha Badar for his guidance and support throughout this journey.
I'm eager to continue advancing this research and contributing to the field of hematology! 💚 🤍 🖤 #ASH2024 #Hematology #PPM1D
Hello #MedTwitter I'm Mobachir El Kettani, a former Research Trainee at Mayo Clinic and a Research Fellow at UIC. Applying for #internalmedicine for #Match2025
Outside of medicine, I love football, writing, playing Daff.
Looking forward to connecting with residents and mentors
I had the honor of being part of a great team under the supervision of the esteemed @TalhaBadarMD
This work was published in @Hemasphere_EHA Journal, 2024;8(S1): 1855-1856, and the abstract was presented at the @EHA_Hematology (EHA) 2024 conference in Madrid.
Mobachir El Kettani retweeted
Chronic Myeloid Leukemia with involvement of Membranous Labyrinth sciencedirect.com/science/ar…
➡️ Unusual case of CML (T315I) with involvement of bilateral inner ear! @kashishshah99 @MobasherK #CML
Mobachir El Kettani retweeted
TP53 mutation in Myeloproliferative neoplasms - @TalhaBadarMD
@MobasherK @Anand_88_Patel @Dr_RoryShallis
#AcuteMyeloidLeukemia #Cancer #MayoClinic #MyeloproliferativeNeoplasms #OncoDaily #Oncology #TP53 #Mutation
oncodaily.com/86546.html
Mobachir El Kettani retweeted
#EHA2024 #EHA24 #poster_session
#TP53m #MPN #mpnsm
Genomic landscape, impact allelic burden, time to progression from CP-AP/BP in TP53m MPN—> AML
TP53m with VAF>40 had poorer outcome.
No significant impact of type of induction on outcome.
Special thanks to #COMMAND_consortium @MobasherK @Anand_88_Patel @Dr_RoryShallis #Jan_Bewersdorf #Ehab_Atallah #Aron_Goldberg #Kashish_Shah #Alex_Coltoff











